2014
E. Pujade-Lauraine, Hilpert, F., Weber, B., Reuss, A., Poveda, A. M., Kristensen, G. B., Sorio, R., Vergote, I. B., Witteveen, P., Bamias, A., Pereira, D., Wimberger, P., Oaknin, A., Mirza, M. Raza, Follana, P., Bollag, D., and Ray-Coquard, I.,
“Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.”,
J Clin Oncol, vol. 32, no. 13, p. 1308, 2014.
S. Pignata, Scambia, G., Katsaros, D., Gallo, C., Pujade-Lauraine, E., De Placido, S., Bologna, A., Weber, B., Raspagliesi, F., Panici, P. B., Cormio, G., Sorio, R., Cavazzini, M. G., Ferrandina, G., Breda, E., Murgia, V., Sacco, C., Cinieri, S., Salutari, V., Ricci, C., Pisano, C., Greggi, S., Lauria, R., Lorusso, D., Marchetti, C., Selvaggi, L., Signoriello, S., Piccirillo, M. C., Di Maio, M., Perrone, F., Cancer, M. Italian Tr, Sein, Gd'Investig, Oncology, M. Negri Gyne, Groups, E. Network of, and Investigators, G. Cancer Int,
“Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial”,
Lancet Oncol, vol. 15, pp. 396-405, 2014.
G. Emons, Gorchev, G., Sehouli, J., Wimberger, P., Stähle, A., Hanker, L., Hilpert, F., Sindermann, H., Grundker, C., and Harter, P.,
“Efficacy and safety of AEZS-108 (INN: zoptarelin doxorubicin acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: a multicenter phase II trial of the AGO-study group (AGO G”,
Gynecol Oncol, vol. 133, pp. 427-32, 2014.
N. Simon Reed, Gomez-Garcia, E., Gallardo-Rincon, D., Barrette, B. A., Baumann, K. H., Friedlander, M. Leonard, Kichenadasse, G., Kim, J. - W., Lorusso, D., Mirza, M. Raza, and Ray-Coquard, I.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S35-41, 2014.
H. Fujiwara, Yokota, H., Monk, B. J., Treilleux, I., Devouassoux-Shisheboran, M., Davis, A., Kim, J. - W., Mahner, S., Stany, M., Pignata, S., Ray-Coquard, I., and Fujiwara, K.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S96-101, 2014.
A. Okamoto, Glasspool, R. M., Mabuchi, S., Matsumura, N., Nomura, H., Itamochi, H., Takano, M., Takano, T., Susumu, N., Aoki, D., Konishi, I., Covens, A., Ledermann, J. A., Mezzanzanica, D., Mezzazanica, D., Steer, C., Millan, D., McNeish, I. A., Pfisterer, J., Kang, S., Gladieff, L., Bryce, J., and Oza, A. M.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S20-5, 2014.
K. Hasegawa, Nagao, S., Yasuda, M., Millan, D., Viswanathan, A., Glasspool, R. M., Devouassoux-Shisheboran, M., Covens, A., Lorusso, D., Kurzeder, C., Kim, J. - W., Gladieff, L., Bryce, J., Friedlander, M. Leonard, and Fujiwara, K.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S90-5, 2014.
F. Amant, Floquet, A., Friedlander, M. Leonard, Kristensen, G. B., Mahner, S., Nam, E. Ji, Powell, M. A., Ray-Coquard, I., Siddiqui, N. Ahmad, Sykes, P., Westermann, A. M., and Seddon, B.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S67-72, 2014.
P. Pautier, Nam, E. Ji, Provencher, D. M., Hamilton, A. L., Mangili, G., Siddiqui, N. Ahmad, Westermann, A. M., Reed, N. Simon, Harter, P., and Ray-Coquard, I.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S73-7, 2014.
J. A. Ledermann, Luvero, D., Shafer, A., O'Connor, D., Mangili, G., Friedlander, M. Leonard, Pfisterer, J., Mirza, M. R., Kim, J. - W., Alexandre, J., Oza, A. M., and Brown, J.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinoma.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S14-9, 2014.
M. Leonard Friedlander, Covens, A., Glasspool, R. M., Hilpert, F., Kristensen, G. B., Kwon, S., Selle, F., Small, W., Witteveen, E., and Russell, P.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S78-82, 2014.
P. Harter, Gershenson, D., Lhomme, C., Lecuru, F., Ledermann, J. A., Provencher, D. M., Mezzanzanica, D., Quinn, M., Maenpaa, J. U., Kim, J. - W., Mahner, S., Hilpert, F., Baumann, K. H., Pfisterer, J., and du Bois, A.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S5-8, 2014.
C. Gourley, Farley, J., Provencher, D. M., Pignata, S., Mileshkin, L. R., Harter, P., Maenpaa, J. U., Kim, J. - W., Pujade-Lauraine, E., Glasspool, R. M., Ray-Coquard, I., and Gershenson, D.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S9-13, 2014.
N. Simon Reed, Pautier, P., Åvall-Lundqvist, E., Choi, C. - H., du Bois, A., Friedlander, M. Leonard, Fyles, A., Kichenadasse, G., Provencher, D. M., and Ray-Coquard, I.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S30-4, 2014.
I. Ray-Coquard, Brown, J., Harter, P., Provencher, D. M., Fong, P. C., Maenpaa, J. U., Ledermann, J. A., Emons, G., Rigaud, D. Berton, Glasspool, R. M., Mezzanzanica, D., and Colombo, N.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S42-7, 2014.
J. Brown, Friedlander, M. Leonard, Backes, F. J., Harter, P., O'Connor, D. M., Rouge, Tde la Mott, Lorusso, D., Maenpaa, J. U., Kim, J. - W., Tenney, M. E., and Seckl, M. J.,
“Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S48-54, 2014.
T. Satoh, Takei, Y., Treilleux, I., Devouassoux-Shisheboran, M., Ledermann, J. A., Viswanathan, A., Mahner, S., Provencher, D. M., Mileshkin, L. R., Åvall-Lundqvist, E., Pautier, P., Reed, N. Simon, and Fujiwara, K.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S102-8, 2014.
R. M. Glasspool, Martín, A. González, Millan, D., Lorusso, D., Åvall-Lundqvist, E., Hurteau, J. A., Davis, A., Hilpert, F., Kim, J. - W., Alexandre, J., and Ledermann, J. A.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S26-9, 2014.
D. Berton-Rigaud, Devouassoux-Shisheboran, M., Ledermann, J. A., Leitao, M. M., Powell, M. A., Poveda, A. M., Beale, P., Glasspool, R. M., Creutzberg, C. L., Harter, P., Kim, J. - W., Reed, N. Simon, and Ray-Coquard, I.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S55-60, 2014.
S. Sagae, Susumu, N., Viswanathan, A., Aoki, D., Backes, F. J., Provencher, D. M., Vaughan, M., Creutzberg, C. L., Kurzeder, C., Kristensen, G. B., Lee, C., Kurtz, J. - E., Glasspool, R. M., and Small, W.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S83-9, 2014.
M. M. Leitao, Cheng, X., Hamilton, A. L., Siddiqui, N. Ahmad, Jürgenliemk-Schulz, I. M., Mahner, S., Åvall-Lundqvist, E., Kim, K., and Freyer, G.,
“Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S117-22, 2014.
M. L. Hensley, Barrette, B. A., Baumann, K. H., Gaffney, D. K., Hamilton, A. L., Kim, J. - W., Maenpaa, J. U., Pautier, P., Siddiqui, N. Ahmad, Westermann, A. M., and Ray-Coquard, I.,
“Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.”,
Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S61-6, 2014.
K. S. Tewari, Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., Michael, H. E., and Monk, B. J.,
“Improved survival with bevacizumab in advanced cervical cancer.”,
N Engl J Med, vol. 370, no. 8, pp. 734-43, 2014.
A. du Bois, Floquet, A., Kim, J. - W., Rau, J., Del Campo, J. M., Friedlander, M. Leonard, Pignata, S., Fujiwara, K., Vergote, I. B., Colombo, N., Mirza, M. R., Monk, B. J., Kimmig, R., Ray-Coquard, I., Zang, R., Diaz-Padilla, I., Baumann, K. H., Mouret-Reynier, M. - A., Kim, J. - H., Kurzeder, C., Lesoin, A., Vasey, P. A., Marth, C., Canzler, U., Scambia, G., Shimada, M., Calvert, P., Pujade-Lauraine, E., Kim, B. - G., Herzog, T. J., Mitrica, I., Schade-Brittinger, C., Wang, Q., Crescenzo, R. J., and Harter, P.,
“Incorporation of pazopanib in maintenance therapy of ovarian cancer.”,
J Clin Oncol, vol. 32, no. 30, p. 3382, 2014.
]